学術論文|株式会社アミンファーマ研究所

Publication Lists: 2020

1. Igarashi, K., Uemura, T., and Kashiwagi, K.: Assessing acrolein for determination of the severity of brain stroke, dementia, renal failure and Sjögren’s syndrome. (Review article)  [Abstract]  Amino Acids 52, 119-127 (2020)
2. Nishimura, K., Okamoto, M., Sibue, R., Mizuta, T., Shibayama, T., Yoshino, T., Murakami, T., Yamaguchi, M., Tanaka, S., Toida, T., and Igarashi, K.: KLF4 is required for suppression of histamine synthesis by polyamines during bone marrow-derived mast cell differentiation. [Abstract] PLoS One 15, e0229744 (2020)
3. Uemura, T., Kanzaki, T., Ishizawa, K., Kashiwagi, K., and Igarashi, K.: Decrease of patients with brain infarction through evaluation of relative risk value of brain infarction by measurement of protein-conjugated acrolein, IL-6 and CRP in plasma together with age. [Abstract] Biomarkers J. 6, 1:65 (2020)
4. Sakamoto, A., Sahara, J., Kawai, G., Yamamoto, K., Ishihama, A., Uemura, T., Igarashi, K., Kashiwagi, K., and Terui, Y.: Cytotoxic mechanism of excess polyamines functions through translational repression of specific proteins encoded by the polyamine modulon. [Abstract] Int. J. Mol. Sci. 21, 2406 (2020)
5. Sakamoto, A., Terui, Y., Uemura, T., Igarashi, K., and Kashiwagi, K.: Polyamines regulate gene expression by stimulating translation of histone acetyltransferase mRNAs. [Abstract] J. Biol. Chem. 295, 8736-8745 (2020)
6. Sridharan, A., Shi, M., Leo, V. I., Subramaniam, N., Lim, T. C., Uemura, T., Igarashi, K., Tien Guan, S. T., Tan, N. S., Vardy, L. A.: The polyamine putrescine promotes human epidermal melanogenesis. [AbstractJ. Invest. Dermatol 140, 2032-2040 (2020)
7. Uju, Y., Kanzaki, T., Yamasaki, Y., Kondo, T., Nanasawa, H., Takeuchi, Y., Yanagisawa, Y., Kusanishi, S., Nakano, C., Enomoto, T., Sako, A., Yanai, H., Mimori, S., Igarashi, K., Takizawa, T., and Hayakawa, T.: Metabolic changes of Japanese schizophrenic patients transferred from hospitalization to outpatients. [AbstractGlob. Health Med. 2, 178-183 (2020)
8. Sakamoto, A., Uemura, T., Terui, Y., Yoshida, M., Fukuda, K., Nakamura, T., Kashiwagi, K., and Igarashi, K.: Development of an ELISA for measurement of urinary 3-hydroxypropyl mercapturic acid (3-HPMA), the marker of stroke. [Abstract] Med. Sci. 8, 33 (2020)
9. Uju, Y., Kanzaki, T., Yamasaki, Y., Kondo, T., Nanasawa, H., Takeuchi, Y., Yanagisawa, Y., Kusanishi, S., Nakano, C., Enomoto, T., Sako, A., Yanai, H., Mishima, S., Mimori, S., Igarashi, K., Takizawa, T., and Hayakawa, T.: A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disorders. [Abstract] Ann. Gen. Psychiatry 19, 53 (2020)
10. Ko, K., Suzuki, T., Ishikawa, R., Hattori, N., Ito, R., Umehara, K., Furihata, T., Dohmae, N., Linhardt, R. J., Igarashi, K., Toida, T., and Higashi, K.: Ischemic stroke disrupts the endothelial glycocalyx through activation of proHPSE via acrolein exposure. [Abstract] J. Biol. Chem. 295, 18614-18624 (2020)
11. Uemura, T., Suzuki, T., Ko, K., Nakamura, M., Dohmae, N., Sakamoto, A., Terui, Y., Toida, T., Kashiwagi, K., and Igarashi, K.: Structural change and degradation of cytoskeleton due to the acrolein conjugation with vimentin and actin during brain infarction. [Abstract] Cytoskeleton 77, 414-421 (2020)

 

学術論文|株式会社アミンファーマ研究所